The Dallas Business Journal covered the fluctuating activity of private investment funds. Gardere's Larry E. Glasgow commented on the private investment market, noting the increasing number of private investment deals.
"We've been seeing more deals, although it's still what I would call choppy," Mr. Glasgow said. "We'll go through a two to three month period where we have almost more than we can handle, then go through a two to three month period where it slows down. In terms of private equity. There's a lot of money sitting on the sidelines waiting to be deployed. I think people are just trying to become comfortable with the current economic landscape."
Subscribers can access the full article here.
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”